Author:
Cornely Oliver A.,Wisplinghoff Hilmar
Publisher
Springer Berlin Heidelberg
Reference75 articles.
1. Aguado JM, Vázquez L, Fernández-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P, Silva JT, Batlle M, Solano C, Gallardo D, Heras I, Polo M, Varela R, Vallejo C, Olave T, López-Jiménez J, Rovira M, Parody R, Cuenca-Estrella M, for the PCRAGA Study Group the Spanish Stem Cell Transplantation Group, the Study Group of Medical Mycology of the Spanish Society of Clinical Microbiology and Infectious Diseases, the Spanish Network for Research in Infectious Diseases (2015) Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial. Clin Infect Dis 60(3):405–414. https://doi.org/10.1093/cid/ciu833. Epub 2014 Oct 21. PMID: 25336623
2. Barragan NC, Sorvillo F, Kuo T (2014) Cryptococcosis-related deaths and associated medical conditions in the United States, 2000–2010. Mycoses. https://doi.org/10.1111/myc.12238. [Epub ahead of print]
3. Bassetti M, Giacobbe DR, Grecchi C, Rebuffi C, Zuccaro V, Scudeller L, FUNDICU investigators (2020) Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis. J Infect 81(1):131–146. https://doi.org/10.1016/j.jinf.2020.03.065. Epub 2020 Apr 21. PMID: 32330523
4. Bidaud AL, Chowdhary A, Dannaoui E (2018) Candida auris: an emerging drug resistant yeast – a mini-review. J Mycol Med 28(3):568–573. https://doi.org/10.1016/j.mycmed.2018.06.007. Epub 2018 Jul 17. PMID: 30030072
5. Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA) (2016) Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. Cryptococcosis (2016, reviewed 2019)